Eupraxia Pharmaceuticals (EPRX.TO) Q1 2026 Earnings

13MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.42
-0.35
-0.28
-0.21

Details

Expected EPS
-0.20747316488113599
Actual EPS
-0.42203862844836
Surprise EPS
-0.21
Surprise Percent
+103.42%

Description

Eupraxia Pharmaceuticals (EPRX.TO) has reported earnings of -0.42203862844836 per share for Q1 2026.

0 Comments

Share your thoughts